ANPEP and fibrosarcoma: APN-targeted NDS have been developed by various groups; for example, after the intravenous injection of the c-Myc siRNA loaded in NGR-modified PEGylated liposomes, they are delivered efficiently to the HT1080 fibrosarcoma cytoplasm.